These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1202 related articles for article (PubMed ID: 28461188)

  • 1. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis.
    Ermarth A; Bryce M; Woodward S; Stoddard G; Book L; Jensen MK
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):396-402.e2. PubMed ID: 27847281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease.
    Oyaert M; Vermeersch P; De Hertogh G; Hiele M; Vandeputte N; Hoffman I; Bossuyt X
    Clin Chem Lab Med; 2015 Sep; 53(10):1537-46. PubMed ID: 25719330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.
    Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.
    Ortiz G; Messere G; Toca MDC; Fiorucci M; Bigliardi R; Vidal J; Reynoso R
    Arch Argent Pediatr; 2019 Feb; 117(1):52-55. PubMed ID: 30652447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive predictive value of serological diagnostic measures in celiac disease.
    Toftedal P; Nielsen C; Madsen JT; Titlestad K; Husby S; Lillevang ST
    Clin Chem Lab Med; 2010 May; 48(5):685-91. PubMed ID: 20201743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in the diagnosis of coeliac disease: a biopsy-controlled, international, multicentre study of 376 children with coeliac disease and 695 controls.
    Wolf J; Hasenclever D; Petroff D; Richter T; Uhlig HH; Laaß MW; Hauer A; Stern M; Bossuyt X; de Laffolie J; Flemming G; Villalta D; Schlumberger W; Mothes T
    PLoS One; 2014; 9(5):e97853. PubMed ID: 24830313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.
    Niveloni S; Sugai E; Cabanne A; Vazquez H; Argonz J; Smecuol E; Moreno ML; Nachman F; Mazure R; Kogan Z; Gomez JC; Mauriño E; Bai JC
    Clin Chem; 2007 Dec; 53(12):2186-92. PubMed ID: 17901114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
    Gould MJ; Brill H; Marcon MA; Munn NJ; Walsh CM
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):20-25. PubMed ID: 30052564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Concentrations Decrease 14-Fold in Children With Celiac Disease on a Gluten-Free Diet but Remain High at 3 Months.
    Petroff D; Wolf J; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Heiduk M; Flemming G; Schmidt A; Hasenclever D; Mothes T
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1442-1449.e5. PubMed ID: 29654912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
    Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
    Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
    Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
    Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological screening for celiac disease in symptomatic 12 to 36 month-old children.
    Modelli IC; Gandolfi L; Almeida RC; Araújo GM; Picanço Mde A; Pratesi R
    Arq Gastroenterol; 2010; 47(1):61-5. PubMed ID: 20520977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
    Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
    Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
    Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
    Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
    Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.